Nonmelanoma Skin Cancer

Dermatologic Clinics

Volumn 30, Issue 1, 2012, Pages 125-139

  Kim, Randie H ^a   Armstrong, April W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Basal cell carcinomas; Nonmelanoma skin cancers; Squamous cell carcinomas; UV exposure

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER;

AGE DISTRIBUTION; BASAL CELL CARCINOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESEARCH; CANCER RISK; CANCER SURGERY; CANCER THERAPY; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CRYOTHERAPY; DISEASE ASSOCIATION; ETHNICITY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HUMAN; METASTASIS; MORBIDITY; NONHUMAN; OUTCOME ASSESSMENT; OZONE DEPLETION; PATIENT CARE; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEX RATIO; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; SURVIVAL RATE; TREND STUDY; ULTRAVIOLET RADIATION;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DERMATOLOGY; HUMANS; INCIDENCE; OUTCOME ASSESSMENT (HEALTH CARE); SKIN NEOPLASMS; UNITED STATES;

EID: 82455220844     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.08.008     Document Type: Review

References (103)

1. Jemal A., Siegel R., Xu J., et al. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300.
2. Scotto J., Fears T.R., Fraumeni J.F., Fred Hutchinson Cancer Research Center, et al. Incidence of nonmelanoma skin cancer in the United States 1983, U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Bethesda (MD).
3. Urbach F. Incidence of nonmelanoma skin cancer. Dermatol Clin 1991, 9(4):751-755.
4. Gloster H.M., Brodland D.G. The epidemiology of skin cancer. Dermatol Surg 1996, 22(3):217-226.
5. Lynch H.T., Fusaro R., Edlund J., et al. Skin cancer developing in xeroderma pigmentosum patient relaxing sunlight avoidance. Lancet 1981, 2(8257):1230.
6. Brash D.E., Rudolph J.A., Simon J.A., et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 1991, 88(22):10124-10128.
7. Fry R.J., Ley R.D. Ultraviolet radiation-induced skin cancer. Carcinog Compr Surv 1989, 11:321-337.
8. Young J.L., Percy C.L., Asire A.J., et al. Surveillance, epidemiology, and end results: incidence and mortality data, 1973-77 1981, U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health. For sale by the Supt. of Docs., U.S. G.P.O, Bethesda (MD), Washington, DC.
9. Scotto J., Kopf A.W., Urbach F. Non-melanoma skin cancer among Caucasians in four areas of the United States. Cancer 1974, 34(4):1333-1338.
10. Miller D.L., Weinstock M.A. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994, 30(5 Pt 1):774-778.
11. Rogers H.W., Weinstock M.A., Harris A.R., et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010, 146(3):283-287.
12. Diepgen T.L., Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002, 146(Suppl 61):1-6.
13. Serrano H., Scotto J., Shornick G., et al. Incidence of nonmelanoma skin cancer in New Hampshire and Vermont. J Am Acad Dermatol 1991, 24(4):574-579.
14. Chuang T.Y., Popescu A., Su W.P., et al. Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota. J Am Acad Dermatol 1990, 22(3):413-417.
15. Chuang T.Y., Popescu N.A., Su W.P., et al. Squamous cell carcinoma. A population-based incidence study in Rochester, Minn. Arch Dermatol 1990, 126(2):185-188.
16. Rigel D.S., Friedman R.J., Kopf A.W. Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5. J Am Acad Dermatol 1996, 35(6):1012-1013.
17. Karagas M.R., Greenberg E.R., Spencer S.K., et al. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 1999, 81(4):555-559.
18. Pearson G., King L.E., Boyd A.S. Basal cell carcinoma of the lower extremities. Int J Dermatol 1999, 38(11):852-854.
19. Reizner G.T., Chuang T.Y., Elpern D.J., et al. Basal cell carcinoma in Kauai, Hawaii: the highest documented incidence in the United States. J Am Acad Dermatol 1993, 29(2 Pt 1):184-189.
20. Weinstock M.A., Bogaars H.A., Ashley M., et al. Nonmelanoma skin cancer mortality. A population-based study. Arch Dermatol 1991, 127(8):1194-1197.
21. Glass A.G., Hoover R.N. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 1989, 262(15):2097-2100.
22. Mora R.G., Perniciaro C. Cancer of the skin in blacks. I. A review of 163 black patients with cutaneous squamous cell carcinoma. J Am Acad Dermatol 1981, 5(5):535-543.
23. Bang K.M., Halder R.M., White J.E., et al. Skin cancer in black Americans: a review of 126 cases. J Natl Med Assoc 1987, 79(1):51-58.
24. McCall C.O., Chen S.C. Squamous cell carcinoma of the legs in African Americans. J Am Acad Dermatol 2002, 47(4):524-529.
25. Gallagher R.P., Ma B., McLean D.I., et al. Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol 1990, 23(3 Pt 1):413-421.
26. Gray D.T., Suman V.J., Su W.P., et al. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 1997, 133(6):735-740.
27. Athas W.F., Hunt W.C., Key C.R. Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico. Cancer Epidemiol Biomarkers Prev 2003, 12(10):1105-1108.
28. Harris R.B., Griffith K., Moon T.E. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996. J Am Acad Dermatol 2001, 45(4):528-536.
29. Stone J.L., Elpern D.J., Reizner G., et al. Incidence of non-melanoma skin cancer in Kauai during 1983. Hawaii Med J 1986, 45(8):281-282. 285-6.
30. Reizner G.T., Chuang T.Y., Elpern D.J., et al. Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population-based incidence report. J Am Acad Dermatol 1994, 31(4):596-600.
31. Qureshi A.A., Laden F., Colditz G.A., et al. Geographic variation and risk of skin cancer in US women. Differences between melanoma, squamous cell carcinoma, and basal cell carcinoma. Arch Intern Med 2008, 168(5):501-507.
32. Giles G.G., Marks R., Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 1988, 296(6614):13-17.
33. Christenson L.J., Borrowman T.A., Vachon C.M., et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005, 294(6):681-690.
34. Bivens M.M., Bhosle M., Balkrishnan R., et al. Nonmelanoma skin cancer: is the incidence really increasing among patients younger than 40? A reexamination using 25 years of U.S. outpatient data. Dermatol Surg 2006, 32(12):1473-1479.
35. Montagna W., Carlisle K. The architecture of black and white facial skin. J Am Acad Dermatol 1991, 24(6 Pt 1):929-937.
36. Halder R.M., Bridgeman-Shah S. Skin cancer in African Americans. Cancer 1995, 75(Suppl 2):667-673.
37. Fleming I.D., Barnawell J.R., Burlison P.E., et al. Skin cancer in black patients. Cancer 1975, 35(3):600-605.
38. Halder R.M., Bang K.M. Skin cancer in blacks in the United States. Dermatol Clin 1988, 6(3):397-405.
39. Singh B., Bhaya M., Shaha A., et al. Presentation, course, and outcome of head and neck skin cancer in African Americans: a case-control study. Laryngoscope 1998, 108(8 Pt 1):1159-1163.
40. Harper J.G., Pilcher M.F., Szlam S., et al. Squamous cell carcinoma in an African American with discoid lupus erythematosus: a case report and review of the literature. South Med J 2010, 103(3):256-259.
41. Matsuoka L.Y., Schauer P.K., Sordillo P.P. Basal cell carcinoma in black patients. J Am Acad Dermatol 1981, 4(6):670-672.
42. Chuang T.Y., Reizner G.T., Elpern D.J., et al. Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report. J Am Acad Dermatol 1995, 33(3):422-426.
43. Chuang T.Y., Reizner G.T., Elpern D.J., et al. Squamous cell carcinoma in Kauai, Hawaii. Int J Dermatol 1995, 34(6):393-397.
44. Abreo F., Sanusi I.D. Basal cell carcinoma in North American blacks. Clinical and histopathologic study of 26 patients. J Am Acad Dermatol 1991, 25(6 Pt 1):1005-1011.
45. Bigler C., Feldman J., Hall E., et al. Pigmented basal cell carcinoma in Hispanics. J Am Acad Dermatol 1996, 34(5 Pt 1):751-752.
46. Eide M.J., Krajenta R., Johnson D., et al. Identification of patients with nonmelanoma skin cancer using health maintenance organization claims data. Am J Epidemiol 2010, 171(1):123-128.
47. Gold H.T., Do H.T. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data. Health Serv Res 2007, 42(5):2056-2069.
48. Baldi I., Vicari P., Di Cuonzo D., et al. A high positive predictive value algorithm using hospital administrative data identified incident cancer cases. J Clin Epidemiol 2008, 61(4):373-379.
49. Epstein E. Value of follow-up after treatment of basal cell carcinoma. Arch Dermatol 1973, 108(6):798-800.
50. Rowe D.E., Carroll R.J., Day C.L. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989, 15(3):315-328.
51. Paver K., Poyzer K., Burry N., et al. Letter: the incidence of basal cell carcinoma and their metastases in Australia and New Zealand. Australas J Dermatol 1973, 14(1):53.
52. Cade S. Malignant disease and its treatment by radium 1940, Williams & Wilkins, Baltimore (MD).
53. Lo J.S., Snow S.N., Reizner G.T., et al. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol 1991, 24(5 Pt 1):715-719.
54. Cotran R.S. Metastasizing basal cell carcinomas. Cancer 1961, 14:1036-1040.
55. Snow S.N., Sahl W., Lo J.S., et al. Metastatic basal cell carcinoma. Report of five cases. Cancer 1994, 73(2):328-335.
56. Sahl W.J. Basal cell carcinoma: influence of tumor size on mortality and morbidity. Int J Dermatol 1995, 34(5):319-321.
57. Katz A.D., Urbach F., Lilienfeld A.M. The frequency and risk of metastases in squamous-cell carcinoma of the skin. Cancer 1957, 10(6):1162-1166.
58. Lund H.Z. How often does squamous cell carcinoma of the skin metastasize?. Arch Dermatol 1965, 92(6):635-637.
59. Epstein E., Epstein N.N., Bragg K., et al. Metastases from squamous cell carcinomas of the skin. Arch Dermatol 1968, 97(3):245-251.
60. Dinehart S.M., Pollack S.V. Metastases from squamous cell carcinoma of the skin and lip. An analysis of twenty-seven cases. J Am Acad Dermatol 1989, 21(2 Pt 1):241-248.
61. Rowe D.E., Carroll R.J., Day C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992, 26(6):976-990.
62. Tavin E., Persky M. Metastatic cutaneous squamous cell carcinoma of the head and neck region. Laryngoscope 1996, 106(2 Pt 1):156-158.
63. Weinberg A.S., Ogle C.A., Shim E.K. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 2007, 33(8):885-899.
64. Marcil I., Stern R.S. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 2000, 136(12):1524-1530.
65. Clayman G.L., Lee J.J., Holsinger F.C., et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005, 23(4):759-765.
66. Weinstock M.A. The epidemic of squamous cell carcinoma. JAMA 1989, 262(15):2138-2140.
67. Lewis K.G., Weinstock M.A. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study. Arch Dermatol 2004, 140(7):837-842.
68. Dunn J.E., Levin E.A., Linden G., et al. Skin cancer as a cause of death. Calif Med 1965, 102:361-363.
69. Weinstock M.A., Bogaars H.A., Ashley M., et al. Inaccuracies in certification of nonmelanoma skin cancer deaths. Am J Public Health 1992, 82(2):278-281.
70. Weinstock M.A. Nonmelanoma skin cancer mortality in the United States, 1969 through 1988. Arch Dermatol 1993, 129(10):1286-1290.
71. Lewis K.G., Weinstock M.A. Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000. J Invest Dermatol 2007, 127(10):2323-2327.
72. Chen J., Ruczinski I., Jorgensen T.J., et al. Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 2008, 100(17):1215-1222.
73. Kahn H.S., Tatham L.M., Patel A.V., et al. Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA 1998, 280(10):910-912.
74. Katz M.R., Irish J.C., Devins G.M., et al. Psychosocial adjustment in head and neck cancer: the impact of disfigurement, gender and social support. Head Neck 2003, 25(2):103-112.
75. Rhee J.S., Matthews B.A., Neuburg M., et al. Creation of a quality of life instrument for nonmelanoma skin cancer patients. Laryngoscope 2005, 115(7):1178-1185.
76. Matthews B.A., Rhee J.S., Neuburg M., et al. Development of the facial skin care index: a health-related outcomes index for skin cancer patients. Dermatol Surg 2006, 32(7):924-934. [discussion: 934].
77. Rhee J.S., Matthews B.A., Neuburg M., et al. Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer. Arch Facial Plast Surg 2006, 8(5):314-318.
78. Rhee J.S., Matthews B.A., Neuburg M., et al. The skin cancer index: clinical responsiveness and predictors of quality of life. Laryngoscope 2007, 117(3):399-405.
79. Chren M.M., Lasek R.J., Sahay A.P., et al. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 2001, 5(2):105-110.
80. Chen T., Bertenthal D., Sahay A., et al. Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. Arch Dermatol 2007, 143(11):1386-1392.
81. Chren M.M., Sahay A.P., Bertenthal D.S., et al. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol 2007, 127(6):1351-1357.
82. Lee K.C., Weinstock M.A. Prospective quality of life impact of keratinocyte carcinomas: observations from the Veterans Affairs Topical Tretinoin Chemoprevention Trial. J Am Acad Dermatol 2010, 63(6):1107-1109.
83. Chen J.G., Fleischer A.B., Smith E.D., et al. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg 2001, 27(12):1035-1038.
84. Joseph A.K., Mark T.L., Mueller C. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by Medicare. Dermatol Surg 2001, 27(11):955-959.
85. Housman T.S., Feldman S.R., Williford P.M., et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003, 48(3):425-429.
86. John Chen G., Yelverton C.B., Polisetty S.S., et al. Treatment patterns and cost of nonmelanoma skin cancer management. Dermatol Surg 2006, 32(10):1266-1271.
87. Manternach T., Housman T.S., Williford P.M., et al. Surgical treatment of nonmelanoma skin cancer in the Medicare population. Dermatol Surg 2003, 29(12):1167-1169. [discussion: 1169].
88. Cook J., Zitelli J.A. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 1998, 39(5 Pt 1):698-703.
89. Bialy T.L., Whalen J., Veledar E., et al. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis. Arch Dermatol 2004, 140(6):736-742.
90. Seidler A.M., Bramlette T.B., Washington C.V., et al. Mohs versus traditional surgical excision for facial and auricular nonmelanoma skin cancer: an analysis of cost-effectiveness. Dermatol Surg 2009, 35(11):1776-1787.
91. Rogers H.W., Coldiron B.M. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. J Am Acad Dermatol 2009, 61(1):96-103.
92. Miller S.J., Alam M., Andersen J., et al. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw 2010, 8(8):836-864.
93. Rowe D.E., Carroll R.J., Day C.L. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989, 15(4):424-431.
94. Bath-Hextall F.J., Perkins W., Bong J., et al. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2007, 1. CD003412.
95. Avril M.F., Auperin A., Margulis A., et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997, 76(1):100-106.
96. Mosterd K., Krekels G.A., Nieman F.H., et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 2008, 9(12):1149-1156.
97. Rhodes L.E., de Rie M.A., Leifsdottir R., et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 2007, 143(9):1131-1136.
98. Mosterd K., Thissen M.R., Nelemans P., et al. Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial. Br J Dermatol 2008, 159(4):864-870.
99. Basset-Seguin N., Ibbotson S.H., Emtestam L., et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 2008, 18(5):547-553.
100. Ozolins M., Williams H.C., Armstrong S.J., et al. The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma. Trials 2010, 11:42.
101. Lansbury L., Leonardi-Bee J., Perkins W., et al. Interventions for non-metastatic squamous cell carcinoma of the skin. Cochrane Database Syst Rev 2010, 4. CD007869.
102. Brewster A.M., Lee J.J., Clayman G.L., et al. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. J Clin Oncol 2007, 25(15):1974-1978.
103. Mudigonda T., Pearce D.J., Yentzer B.A., et al. The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw 2010, 8(8):888-896.